choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Byetta

Byetta Newsletter
  • Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients 31 Jan 2025 14:12 GMT

    … additional therapeutic uses, including treatment for obstructive sleep apnea … ; that was exenatide (Byetta; Amylin Pharmaceuticals, Eli Lilly). The … clinical trials underway looking at if these drugs may … not magic pills. They're serious medications, and …

  • GLP-1 drug approvals: A breakdown 30 Jan 2025 01:17 GMT

    As of Jan. 29, the FDA has approved more than a … :  Amneal Pharmaceuticals'; exenatide, a therapeutical equivalent for Novo Nordisk's Byetta … with Type 2 diabetes Hikma Pharmaceuticals'; liraglutide, a therapeutical equivalent …

  • Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025 28 Jan 2025 17:58 GMT

    … a 68-week clinical trial involving 1,961 adults … side effects, see the Byetta medication guide or talk to your … FDA-approved purposes. For example, while type 2 diabetes drugs … a substitute for professional medical advice or treatment. Please consult your …

  • Bariatric Surgeons Face Decline As GLP-1s Gain Ground In Obesity Treatment 08 Jan 2025 23:24 GMT

    … the next decade. Two pharmaceutical companies, Novo Nordisk and … and Drugs Administration (FDA) has approved ten GLP-1 medication brands … (dulaglutide) – type-2 diabetes Byetta (exenatide) – type-2 diabetes … for this weight loss treatment is a fleeting moment …

  • Which GLP-1 drugs are on the market? 08 Jan 2025 11:50 GMT

    … of GLP-1 drugs, is a medication for the treatment of type 2 … name Bydureon. Former exenatide brand Byetta has, according to Diabetes UK … do? The drug is mainly prescribed as a treatment for type 2 …

  • One Step Closer to a Cure: Breakthrough “Harmine Pill” Sparks Hope for 500 Million Diabetics Worldwide 31 Dec 2024 01:14 GMT

    … Medicine, could mark a significant step forward in diabetes treatment. … ) drugs such as semaglutide (e.g., Ozempic) and exenatide (Byetta) … described in Nature Medicine in 2015. “A simple pill, perhaps together … these studies to human trials. The work has been …

  • First Generic of a GLP-1 Injection Gets FDA Nod to Treat Type 2 Diabetes 27 Dec 2024 19:10 GMT

    … (1). "Generic drugs provide additional treatment options which are generally … of medications in November 2024, when it approved a generic referencing Byetta … Pharmaceuticals. Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA …

  • FDA Approves Generic GLP-1 Medicine For Diabetes Treatment 26 Dec 2024 18:58 GMT

    … the FDA’s Office of Generic Drugs, said. “Generic drugs provide additional treatment options … of medications with the green lighting of a generic version of Byetta … effects reported in the clinical trials for liraglutide injection include nausea …

  • FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes 24 Dec 2024 23:52 GMT

    … to Hikma Pharmaceuticals USA Inc. The first generic GLP-1, Byetta (exenatide … weight loss medication. “The FDA supports development of complex generic drugs, such as … news release. "Generic drugs provide additional treatment options which are generally …

  • FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes 23 Dec 2024 23:53 GMT

    … (Victoza; Hikma Pharmaceuticals), an 18 mg … medications to receive FDA approval, a generic referencing exenatide (Byetta … quot;Generic drugs provide additional treatment options which … drug products.” The most commonly reported adverse events in clinical trials …

Satisfied with the content?

Continue to create your account.